AGO-OVAR 12: A Randomized Placebo-controlled GCIG/ENGOT-Intergroup Phase III trial of standard frontline chemotherapy plus /- Nintedanib for advanced ovarian cancerP. Harter, R. Kimmig,N. de Gregorio,A. Reuss,J. Pfisterer, D. Cibula,F. Hilpert,W. Meier,L. C. Hanker,U. Canzler,J. Sehouli,K. Baumann,A. Burges, M. Gropp-Meier,A. Hasenburg,A. Belau,T. Fehm, J. Kosse,S. Mahner,B. Schmalfeldt,F. Marme,B. Richter,U. Herwig,C. Liebrich, B. Gerber,J. Potenberg, P. Krabisch, M. Thill,M. Merger, A. du BoisONCOLOGY RESEARCH AND TREATMENT（2014）引用 1|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
